Tolfenamic Acid Derivatives: A New Class of Transcriptional Modulators with Potential Therapeutic Applications for Alzheimer's Disease and Related Disorders.

Int J Mol Sci · 2023 · PMC10607430 · PMID 37894896

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Our results demonstrated that treatment TA or its analogs showed a trend toward decreased SP1-DNA binding to the promoter regions of APP and Tau genes ( Figure 2 C).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.